ENTITY

G1 Therapeutics (GTHX US)

Analysis

Health Care • United States

G1 Therapeutics, Inc. is a pharmaceutical company. The Company develops novel therapeutics for the treatment of oncology and breast cancer. G1 Therapeutics serves the healthcare sector in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00